The Long Run Economic Effects of Medical Innovation and the Role of Opportunities

Sonia R. Bhalotra (), Damian Clarke and Atheendar Venkataramani ()
Additional contact information
Sonia R. Bhalotra: University of Warwick
Atheendar Venkataramani: Massachusetts General Hospital

No 18327, IZA Discussion Papers from IZA Network @ LISER

Abstract: We leverage the introduction of the first antibiotic therapies in 1937 to examine the long-run effects of early-childhood pneumonia on adult educational attainment, employment, income, and work-related disability. Using census data, we document large average gains on all outcomes, alongside substantial heterogeneity by race and gender. On average, Black men exhibit smaller schooling gains than white men but larger employment and earnings gains. Among Black men (and women), we identify a pronounced gradient in gains linked to systemic racial discrimination in the pre–Civil Rights era: individuals born in more discriminatory Jim Crow states realized much smaller gains than those born in less discriminatory states. There is no similar gradient among white Americans. Women of both races exhibit smaller education and earnings gains than men on average, consistent with cultural and institutional barriers to women’s work. Our findings highlight the role of opportunities in shaping the extent to which investments in early-life health translate into longer run economic gains.

Keywords: medical innovation; race; human capital production; education; income; disability; systemic discrimination; institutions; infectious disease; early childhood; pneumonia; antibiotics; sulfa drugs (search for similar items in EconPapers)
JEL-codes: H70 I10 I14 J71 (search for similar items in EconPapers)
Date: 2025-12
New Economics Papers: this item is included in nep-eur, nep-hea, nep-his and nep-lma
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://docs.iza.org/dp18327.pdf (application/pdf)

Related works:
Working Paper: The Long Run Economic Effects of Medical Innovation and the Role of Opportunities (2026)
Working Paper: The Long Run Economic Effects of Medical Innovation and the Role of Opportunities (2026)
Working Paper: The Long Run Economic Effects of Medical Innovation and the Role of Opportunities (2026)
Working Paper: The long run economic effects of medical innovation and the role of opportunities (2026)
Working Paper: The Long Run Economic Effects of Medical Innovation and the Role of Opportunities (2026)
Working Paper: The Long Run Economic Effects of Medical Innovation and the Role of Opportunities (2025)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:iza:izadps:dp18327

Access Statistics for this paper

More papers in IZA Discussion Papers from IZA Network @ LISER Contact information at EDIRC.
Bibliographic data for series maintained by Mark Fallak ().